DNMT1-Induced miR-152-3p Suppression Facilitates Cardiac Fibroblast Activation in Cardiac Fibrosis
-
Published:2021-08-23
Issue:12
Volume:21
Page:984-999
-
ISSN:1530-7905
-
Container-title:Cardiovascular Toxicology
-
language:en
-
Short-container-title:Cardiovasc Toxicol
Author:
Xu Sheng-Song,Ding Ji-Fei,Shi Peng,Shi Kai-Hu,Tao Hui
Funder
Natural Science Foundation of Anhui Provincial
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference25 articles.
1. Russo, I., Cavalera, M., Huang, S., Su, Y., Hanna, A., Chen, B., Shinde, A. V., Conway, S. J., Graff, J., & Frangogiannis, N. G. (2019). Protective effects of activated myofibroblasts in the pressure-overloaded myocardium are mediated through smad-dependent activation of a matrix-preserving program. Circulation Research, 124, 1214–1227. 2. Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., Wang, T., Bedi, K., Morley, M. P., Linares Saldana, R. A., Bolar, N. A., McDaid, K., Assenmacher, C. A., Smith, C. L., Wirth, D., … Epstein, J. A. (2019). Targeting cardiac fibrosis with engineered T cells. Nature, 573, 430–433. 3. Nagaraju, C. K., Robinson, E. L., Abdesselem, M., Trenson, S., Dries, E., Gilbert, G., Janssens, S., Van Cleemput, J., Rega, F., Meyns, B., Roderick, H. L., Driesen, R. B., & Sipido, K. R. (2019). Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure. Journal of the American College of Cardiology, 73, 2267–2282. 4. Villalobos, E., Criollo, A., Schiattarella, G. G., Altamirano, F., French, K. M., May, H. I., Jiang, N., Nguyen, N. U. N., Romero, D., Roa, J. C., Garcia, L., Diaz-Araya, G., Morselli, E., Ferdous, A., Conway, S. J., Sadek, H. A., Gillette, T. G., Lavandero, S., & Hill, J. A. (2019). Fibroblast primary cilia are required for cardiac fibrosis. Circulation, 139, 2342–2357. 5. Friebel, J., Weithauser, A., Witkowski, M., Rauch, B. H., Savvatis, K., Dorner, A., Tabaraie, T., Kasner, M., Moos, V., Bosel, D., Gotthardt, M., Radke, M. H., Wegner, M., Bobbert, P., Lassner, D., Tschope, C., Schutheiss, H. P., Felix, S. B., Landmesser, U., & Rauch, U. (2019). Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction. European Heart Journal. https://doi.org/10.1093/eurheartj/ehz117
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|